Iraj Sharifi
Overview
Explore the profile of Iraj Sharifi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
1348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Salari Z, Khosravi A, Pourkhandani E, Molaakbari E, Salarkia E, Keyhani A, et al.
Front Oncol
. 2023 Mar;
13:1098429.
PMID: 36937441
Background: Epithelial ovarian cancer is very common in women and causes hundreds of deaths per year worldwide. Chemotherapy drugs including cisplatin have adverse effects on patients' health. Complementary treatments and...
22.
Sharifi F, Mohamadi N, Oliaee R, Sharifi I, Doostmohammadi M, Soltanian S, et al.
J Parasit Dis
. 2023 Mar;
47(1):131-139.
PMID: 36910317
The goal of this study was to analyze the antileishmanial and antibacterial activity of green seed biosynthesize silver nanoparticles ( AgNPs), as well as cytotoxicity and cytokine gene expression. UV-vis...
23.
Sharifi F, Sharifi I, Babaei Z, Alahdin S, Afgar A
J Pathol Inform
. 2023 Jan;
14:100190.
PMID: 36700237
Background: GP63, also known as Leishmanolysin, is a multifunctional virulence factor abundant on the surface of spp. small peptides with anticancer capabilities that are selective and toxic to cancer cells...
24.
Bamorovat M, Sharifi I, Agha Kuchak Afshari S, Karamoozian A, Tahmouresi A, Heshmatkhah A, et al.
Int J Parasitol Drugs Drug Resist
. 2022 Dec;
21:21-27.
PMID: 36525935
Leishmaniasis is an overlooked, poverty-stricken, and complex disease with growing social and public health problems. In general, leishmaniasis is a curable disease; however, there is an expansion of unresponsive cases...
25.
Mohamadi N, Sharifi I, Afgar A, Sharififar F, Sharifi F
Acta Parasitol
. 2022 Nov;
68(1):103-113.
PMID: 36434380
Purpose: Cuminaldehyde (CA), an oxidized aldehyde monoterpene, is a major essential oil component in cumin seeds, which has shown different promising medical effects. In this study, we comprehensively evaluated the...
26.
Khaksar Baniasadi A, Ayatollahi Mosavi S, Sharifi I, Bamorovat M, Salari S, Ahmadi A, et al.
J Obstet Gynaecol Res
. 2022 Oct;
48(12):3292-3303.
PMID: 36184563
Aim: Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of...
27.
Jafarzadeh A, Nemati M, Aminizadeh N, Bodhale N, Sarkar A, Jafarzadeh S, et al.
PLoS Pathog
. 2022 Aug;
18(8):e1010696.
PMID: 35925884
As effector innate immune cells and as a host to the protozoan parasite Leishmania, macrophages play a dual role in antileishmanial immunoregulation. The 2 key players in this immunoregulation are...
28.
Bahrami F, Masoudzadeh N, van Veen S, Persson J, Lari A, Sarvnaz H, et al.
Mol Immunol
. 2022 Jul;
149:165-173.
PMID: 35905592
Cutaneous leishmaniasis (CL) is a neglected tropical disease with severe morbidity and socioeconomic sequelae. A better understanding of underlying immune mechanisms that lead to different clinical outcomes of CL could...
29.
Salari S, Bamorovat M, Sharifi I, Almani P
J Clin Lab Anal
. 2022 Jul;
36(8):e24599.
PMID: 35808933
Background: Pentavalent antimonials (Sb(V)) such as meglumine antimoniate (Glucantime®) and sodium stibogluconate (Pentostam®) are used as first-line treatments for leishmaniasis, either alone or in combination with second-line drugs such as...
30.
Javadi A, Khamesipour A, Ghoorchi M, Bahrami M, Khatami A, Sharifi I, et al.
PLoS Negl Trop Dis
. 2022 Jul;
16(7):e0010569.
PMID: 35802749
Treatment of Cutaneous leishmaniasis (CL) is based on using antimoniate derivatives; patients' compliance for systemic injections is low due to the pain and systemic complications. In this randomized open trial,...